Sequential vs concurrent chemoradiation for stage III non–small cell lung cancer: randomized phase III trial RTOG 9410

WJ Curran Jr, R Paulus, CJ Langer… - Journal of the …, 2011 - academic.oup.com
Background The combination of chemotherapy with thoracic radiotherapy (TRT) compared
with TRT alone has been shown to confer a survival advantage for good performance status …
被引用次数：1402 相关文章

Sequential vs concurrent chemoradiation for stage iii non-small cell lung cancer: Randomized phase III trial RTOG 9410

WJ Curran, R Paulus, CJ Langer, R Komaki… - Journal of the National …, 2011 - pure.psu.edu
Background The combination of chemotherapy with thoracic radiotherapy (TRT) compared
with TRT alone has been shown to confer a survival advantage for good performance status …

Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410

WJ Curran Jr, R Paulus, CJ Langer… - Journal of the …, 2011 - pubmed.ncbi.nlm.nih.gov
Background The combination of chemotherapy with thoracic radiotherapy (TRT) compared
with TRT alone has been shown to confer a survival advantage for good performance status …

[引用][C] Sequential vs Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer: Randomized Phase III Trial RTOG 9410

WJ Curran, R Paulus, CJ Langer, R Komaki… - JNCI Journal of the …, 2011 - cir.nii.ac.jp
Sequential vs Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer:
Randomized Phase III Trial RTOG 9410 | CiNii Research CiNii 国立情報学研究所 学術情報 …

Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410.

WJ Curran Jr, R Paulus, CJ Langer… - Journal of the …, 2011 - europepmc.org
Background The combination of chemotherapy with thoracic radiotherapy (TRT) compared
with TRT alone has been shown to confer a survival advantage for good performance status …

Sequential vs Concurrent Chemoradiation for Stage III Non–Small Cell Lung Cancer: Randomized Phase III Trial RTOG 9410.

WJ Curran, R Paulus, CJ Langer… - JNCI: Journal of the …, 2011 - search.ebscohost.com
Background The combination of chemotherapy with thoracic radiotherapy (TRT) compared
with TRT alone has been shown to confer a survival advantage for good performance status …
[HTML] nih.gov

[HTML][HTML] Sequential vs Concurrent Chemoradiation for Stage III Non–Small Cell Lung Cancer: Randomized Phase III Trial RTOG 9410

WJ Curran Jr, R Paulus, CJ Langer… - JNCI Journal of the …, 2011 - ncbi.nlm.nih.gov
Background The combination of chemotherapy with thoracic radiotherapy (TRT) compared
with TRT alone has been shown to confer a survival advantage for good performance status …

[引用][C] Sequential vs Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer: Randomized Phase III Trial RTOG 9410

WJ CURRAN, R PAULUS, M MACHTAY… - Journal of the …, 2011 - pascal-francis.inist.fr
Sequential vs Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer:
Randomized Phase III Trial RTOG 9410 CNRS Inist Pascal-Francis CNRS Pascal and …

Sequential vs concurrent chemoradiation for stage iii non-small cell lung cancer: Randomized phase III trial RTOG 9410

WJ Curran, R Paulus, CJ Langer… - Journal of the …, 2011 - mdanderson.elsevierpure.com
Background The combination of chemotherapy with thoracic radiotherapy (TRT) compared
with TRT alone has been shown to confer a survival advantage for good performance status …
[PDF] researchgate.net

[PDF][PDF] Sequential vs Concurrent Chemoradiation for Stage III Non–Small Cell Lung Cancer: Randomized Phase III Trial RTOG 9410

WJ Curran Jr, R Paulus, CJ Langer, R Komaki… - J Natl Cancer …, 2011 - researchgate.net
Background The combination of chemotherapy with thoracic radiotherapy (TRT) compared
with TRT alone has been shown to confer a survival advantage for good performance status …